Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-110
SponsorUniversity Hospital, Brest

About this trial

Study of the diagnostic performance of 18-FDG PET scores in Polymyalgia rheumatica and comparaison with others inflammatories diseases.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Having 18-FDG PET-CT between 2012 and 2024

Diagnosis of inflammatory rheumatism by specialist doctor

Adult without opposition to use there data for research

Affiliate to social security system

Disqualifiers

Refusal participation

Patient under juridic protection

Trial population

Adult with inflammatory rheumatism confirmed by specialist, with or without treatment and having a 18-FDG-PET CT.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Diagnostic performance of 18-FDG PET scores for diagnostic of Polymyalgia rheumatica.

Evaluation of the metabolism of mains joints compared to liver. Calculation of different scores described in literature.

Time frame
up to 9 months

Secondary outcomes

1

Analysis of SUV and visual fixation of mains joints.

Measure of SUV of mains joints and evaluation of the fixation compared to liver.

Time frame
up to 9 months
2

Diagnostic performance of 18-FDG PET scores for diagnostic of others inflammatory rheumatism.

Evaluation of the precedent scores for diagnosis of others rheumatisms. Creation of others scores if some joints seem to be interesting.

Time frame
up to 9 months
3

Comparaison of scores with clinical, biological and radiological data.

Search for correlation between scores and symptoms, blood test or CT/MRI exams.

Time frame
up to 9 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: